Document is current
Any future updates will be listed below
-
Authors
Tan, Vivian S.
Tjong, Michael C.
Chan, Wing C.
Yan, Michael
Delibasic, Victoria
Darling, Gail
Davis, Laura E.
Doherty, Mark
Hallet, Julie
Kidane, Biniam
Mahar, Alyson
Mittmann, Nicole
Parmar, Ambica
Tan, Hendrick
Wright, Frances C.
Coburn, Natalie G.
Louie, Alexander V.
-
Funding
Funding for this research was provided by:
Ontario Institute of Cancer Research Grant
- License Information
-
More Information
Article History
Received: 8 February 2024
Accepted: 14 May 2024
First Online: 24 May 2024
Declarations
:
: M.D. reports consulting fees from Eisai, Boehringer Ingelheim, Roche, and Takeda, as well as consulting fees and research funding from Merck and AstraZeneca. J.H. reports honoraria from Ipsen and Advanced Accelerator Applications. B.K. reports being on the scientific advisory board for AstraZeneca. N.C. reports honoraria from AstraZeneca. A.L. reports honoraria from AstraZeneca. N.M. is an employee of CADTH. H.T. reports honoraria from AstraZeneca and being on the advisory board for Roche. All other authors have no disclosures.
: Patient consent was waived. ICES is a prescribed entity under Section 45 of Ontario’s Personal Health Information Protection Act. Section 45 authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of the allocation of resources to or planning for all or part of the health system. This project was conducted under Section 45 and approved by ICES’ Privacy and Legal Office.
: M.D. reports consulting fees from Eisai, Boehringer Ingelheim, Roche, and Takeda, as well as consulting fees and research funding from Merck and AstraZeneca. J.H. reports honoraria from Ipsen and Advanced Accelerator Applications. B.K. reports being on the scientific advisory board for AstraZeneca. N.C. reports honoraria from AstraZeneca. A.L. reports honoraria from AstraZeneca. N.M. is an employee of CADTH. H.T. reports honoraria from AstraZeneca and being on the advisory board for Roche. All other authors have no disclosures.
